Stay updated with breaking news from Stephen mayo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and nine have given a buy recommendation […] ....
Absci, a leader in AI drug creation, and the California Institute of Technology (Caltech) have received a grant from the Bill & Melinda Gates Foundation. ....
Vancouver-based Absci partners with Caltech on HIV vaccine research columbian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from columbian.com Daily Mail and Mail on Sunday newspapers.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Equities researchers at HC Wainwright increased their Q3 2023 EPS estimates for Allogene Therapeutics in a report issued on Monday, August 7th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.48) per share for the quarter, up from their prior estimate […] ....
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and nine have given a buy recommendation […] ....